Laddar...
Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease.
Mesalazine is widely used in the treatment of inflammatory bowel disease. Little is known about the dose-response relationship and about possible dose related side effects. In ulcerative colitis higher dosages of mesalazine (3 g) are more effective in maintaining a remission than lower dosages (1.5...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
1998
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1781839/ https://ncbi.nlm.nih.gov/pubmed/9705596 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|